Golrang Pharmaceutical Investment Company’s HSE and IMS Training course was held in the Golrang Company Company’s building on June 19th, 2022, with the HSE committee.
According to the enactment of the Golrang Pharmaceutical Investment Company’s Board of Directors members on the evaluation of the subsidiary’s HSE and establishment of the HSE committee at the interval of three months with the presence of the subsidiaries’ HSE officials and the HSE consultant (secretary of the committee) Dr. Adelizadeh to evaluate (exciting challenges, presenting a necessary solution and decision making regarding the planning, continues improvement and reformation of the work environment) and increasing the safety level was held at the Golrang Pharmaceutical Investment Company central office conference hall at June 19th, 2022.
